ZWO Unveils Seestar S30: The Next Frontier in Accessible Astrophotography at CES 2025

SUZHOU, China, Jan. 3, 2025 /PRNewswire/ — ZWO, a leader in astrophotography…

Zuowei Technology will attend CES 2025 & launch intelligent care robots and solutions

SHENZHEN, China, Jan. 3, 2025 /PRNewswire/ — 2025 CES (International Consumer Electronics Show)…

OneConstruction Group Limited Announces Closing of Initial Public Offering

NEW YORK, Jan. 3, 2025 /PRNewswire/ — OneConstruction Group Limited ("OneConstruction Group"…

Cathay United Bank Launches First "Taiwan Premium Health Check-Up & Accommodation" Package for Affluent Cambodian Customers

TAIPEI, Jan. 3, 2025 /PRNewswire/ — With over a decade of experience…

2025 Foxconn TLPGA Players Championship Returns With New Benchmark Of US$1.5 Million Purse

Women pro golfers in top 100 among competitors in 2nd annual tournament…

Another Power Grid Project for Bingdi Integration Put into Operation, Significantly Enhancing the Power Supply Capacity of Shihezi Power Grid

SHIHEZI, China, Jan. 3, 2025 /PRNewswire/ — On January 2nd, the State…

SK hynix to Unveil 'Full Stack AI Memory Provider' Vision at CES 2025

– SK hynix to showcase technological capabilities, participating in the world’s largest…

Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration

SAN FRANCISCO and SUZHOU, China, Jan. 3, 2025 /PRNewswire/ — Innovent Biologics,…